More

    Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer



    [
    Akeso's Penpulimab Receives NMPA Approval for First-Line Treatment of Nasopharyngeal Cancer
    [og_img]
    https://www.investing.com/news/press-releases/akesos-penpulimab-receives-nmpa-approval-for-firstline-treatment-of-nasopharyngeal-cancer-93CH-3931034


    Investing.com

    Latest articles

    spot_imgspot_img

    Related articles

    Leave a reply

    Please enter your comment!
    Please enter your name here

    spot_imgspot_img